GK Wealth Management »

Arcutis Biotherapeutics shares owned by GK Wealth Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by GK Wealth Management from 13F filings

Historical chart of GK Wealth Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by GK Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by GK Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $332k 18k 18.85
2025-06-30 $264k 19k 14.02
2025-03-31 $229k 15k 15.64

More positions owned by GK Wealth Management

Lithium Amers Corp Com Shs (LAC)
Amazon (AMZN)
Tesla Motors (TSLA)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Ishares Silver Tr Ishares (SLV)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Meta Platforms Cl A (META)
Apple (AAPL)
Vanguard Specialized Funds Div App Etf (VIG)
Fidelity Wise Origin Bitcoin SHS (FBTC)

View all positions for GK Wealth Management

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Rubric Capital Management
Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Vanguard Group
Polar Capital Holdings
State Street Corporation
Gilder, Gagnon, Howe & Co
Morgan Stanley
UBS Group
Geode Capital Management
Henderson Group
Franklin Resources
Pivotal bioVenture Partners Investment Advisor

View all funds holding Arcutis Biotherapeutics